ALLURION TECHNOLOGIES, INC.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
The following list of exhibits includes exhibits submitted with this Quarterly Report on Form 10-Q as filed with the SEC and those incorporated by reference to other filings.
| ExhibitNumber | Description | Incorporated by Reference herein from - Form or Schedule | File Number | Exhibit | Filed Date |
|---|---|---|---|---|---|
| 3.1 | Amended and Restated Certificate of Incorporation of Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) | 8-K | 001-41767 | 3.1 | August 7, 2023 |
| 3.2 | Bylaws of Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) | 8-K | 001-41767 | 3.2 | August 7, 2023 |
| 4.1 | Warrant Agreement, dated February 4, 2021, between Compute Health Acquisition Corp. and Continental Stock Transfer & Trust Company, as warrant agent. | 8-K | 001-40001 | 4.1 | February 9, 2021 |
| 4.2 | Amendment to Warrant Agreement, dated August 1, 2023, by and between Compute Health and Continental Stock Transfer & Trust Company. | 8-K | 001-41767 | 4.2 | August 7, 2023 |
| 4.3 | Warrant Assignment, Assumption and Amendment Agreement, dated August 1, 2023, by and among Compute Health Acquisition Corp., New Allurion Holdings, Inc., and Continental Stock Transfer & Trust Company. | 8-K | 001-41767 | 4.3 | August 7, 2023 |
| 4.4 | Form of Public Warrant. | 8-K | 001-41767 | 4.1 | July 1, 2024 |
| 4.5 | Form of Private Placement Warrant. | 8-K | 001-41767 | 4.2 | July 1, 2024 |
| 4.6 | Form of Common Warrant (January 2025). | 8-K | 001-41767 | 4.1 | January 28, 2025 |
| 4.7 | Form of Common Warrant (February 2025). | 8-K | 001-41767 | 4.1 | February 21, 2025 |
| 4.8 | Form of Private Placement Warrant (February 2025). | 8-K | 001-41767 | 4.2 | February 21, 2025 |
| 10.1# | Omnibus Amendment, dated as of January 7, 2025, by and among Allurion Technologies, Inc., Allurion Technologies, LLC, Allurion Technologies Australia Pty Ltd, Allurion France, RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., RTW Biotech Opportunities Operating Ltd., and RTW Investments, L.P. | S-1/A | 333-283701 | 10.49 | January 8, 2025 |
| 10.2 | Subscription Agreement, dated as of January 14, 2025, by and between Allurion Technologies, Inc. and the purchasers named therein. | 8-K | 001-41767 | 10.1 | January 17, 2025 |
| 10.3 | Securities Purchase Agreement, dated as of January 24, 2025, by and between Allurion Technologies, Inc. and the purchasers named therein. | 8-K | 001-41767 | 10.1 | January 28, 2025 |
| 10.4 | Form of Securities Purchase Agreement. | 8-K | 001-41767 | 10.1 | February 21, 2025 |
| 10.5 | Subscription Agreement, dated as of February 19, 2025, between Allurion Technologies, Inc. and the investors named therein. | 8-K | 001-41767 | 10.2 | February 21, 2025 |
| 10.6 | Second Amendment to Note Purchase Agreement, dated as of April 15, 2025, by and among Allurion Technologies, Inc., the purchasers party thereto, and RTW Investments, LP, as agent for the purchasers. | 8-K | 001-41767 | 10.1 | April 17, 2025 |
| 31.1* | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1** | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
- Filed herewith.
** Furnished herewith
Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.